AU2013204596A1 — Compositions and methods for treating diseases of the nail
Assigned to Dow Pharmaceutical Sciences Inc · Expires 2013-05-09 · 13y expired
What this patent protects
Abstract Methods and compositions for treating disorders of the nail and nail bed. Such compositions do not form a film upon application to the surface of the nail and contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified,…
USPTO Abstract
Abstract Methods and compositions for treating disorders of the nail and nail bed. Such compositions do not form a film upon application to the surface of the nail and contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, and which composition is effective in treating a disorder of the nail or nail bed. (Figure 1) 12.0% 0 10.0% 0 8.0% 4-I 6.0% (U) C. o< S4.0% 2.0% 0.0% 23137078 2313-080 2313-082 2313-107 Figure 1 SUBSTITUTE SHEET (RULE 26)
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.